Article Information
History
- June 20, 2020.
Article Versions
- Version 1 (April 3, 2020 - 10:06).
- Version 2 (April 15, 2020 - 08:30).
- Version 3 (May 22, 2020 - 12:18).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Giuseppe Gritti, MD1,*,
- Federico Raimondi, MD1,
- Diego Ripamonti, MD1,
- Ivano Riva, MD1,
- Francesco Landi, MD1,
- Leonardo Alborghetti1,
- Marco Frigeni, MD1,
- Marianna Damiani, MD1,
- Caterina Micò, MD1,
- Stefano Fagiuoli, MD1,
- Roberto Cosentini, MD1,
- Ferdinando Luca Lorini, MD1,
- Lucia Gandini, MD1,
- Luca Novelli, MD1,
- Jonathan P Morgan, MD2,
- Benjamin M J Owens, PhD2,
- Karan J K Kanhai, MD2,
- Gordana Tonkovic Reljanovic, MD3,
- Marco Rizzi, MD1,
- Fabiano Di Marco, MD4 and
- Alessandro Rambaldi, MD4
- 1Azienda Socio Sanitario Territoriale Papa Giovanni XXIII Hospital, Bergamo, Italy
- 2EUSA Pharma, Hemel Hempstead, UK
- 3ErgoMed PLC Guildford, UK
- 4University of Milan, Milan, Italy
- ↵*Corresponding author details:
Giuseppe Gritti, UOC Ematologia, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Piazza OMS, 1, 24127 Bergamo, Italy, Email: g.gritti{at}asst-pg23.it, Telephone: +39 035 2673684